Physician profile
Anna Jones
NPI 1760880041
$2,267.10
in general payments reported to CMS, 2019-2025
25 companies · $132 in 2025
The $132 reported for 2025 was more than what a typical Registered Nurse provider received nationally (typical 2025 total: $73.55).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $815 · 2022: $810 · 2023: $510 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $572 · Education: $69.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $572.34 |
| Education | $69.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $777.08 | 2021-2023 | Jemperli, Zejula |
| Takeda Pharmaceuticals U.S.A., INC. | $300.95 | 2021-2023 | Alunbrig, Hyqvia |
| Astrazeneca Pharmaceuticals LP | $202.13 | 2023-2025 | |
| Abbvie INC. | $171.17 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $150.87 | 2021 | |
| Incyte Corporation | $82.98 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $73.07 | 2021-2023 | Imbruvica |
| Janssen Biotech, INC. | $52.03 | 2022-2023 | Tecvayli, Darzalex |
| Celgene Corporation | $45.24 | 2022-2023 | Pomalyst |
| Amgen INC. | $42.24 | 2022 | |
| Pfizer INC. | $34.64 | 2022 | |
| Servier Pharmaceuticals LLC | $30.78 | 2021-2022 | |
| Acrotech Biopharma INC. | $30.68 | 2021-2023 | Beleodaq |
| Blueprint Medicines Corporation | $27.16 | 2022 | |
| Lilly USA, LLC | $27.10 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $26.09 | 2022 | |
| Merck Sharp & Dohme LLC | $24.90 | 2022 | |
| Deciphera Pharmaceuticals INC. | $22.87 | 2023 | Qinlock |
| Alexion Pharmaceuticals, INC. | $22.20 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.12 | 2021 | |
| Gilead Sciences, INC. | $21.95 | 2023 | Trodelvy |
| Eisai INC. | $21.77 | 2022 | |
| Daiichi Sankyo INC. | $20.60 | 2022 | |
| Seagen INC. | $20.56 | 2022 | |
| Adc Therapeutics America, INC. | $15.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.